Berberine vs. Metformin: What the Research Actually Says

Last reviewed: June 1, 2026 · Reviewed by the YourHealthier Science Team · Editorial Policy

How does berberine compare to metformin?

Berberine matched metformin for blood sugar reduction in the only published head-to-head randomized controlled trial. According to first author Jun Yin at Pennington Biomedical Research Center (Louisiana State University), 36 adults with newly diagnosed blood sugar concerns took either 500 mg berberine or 500 mg metformin three times daily for 3 months. The berberine group saw HbA1c drop from 9.5% ± 0.5% to 7.5% ± 0.4%, a 21% relative reduction, statistically comparable in effect size to metformin in controlled trials group (Yin et al., 2008, Metabolism, PubMed).

That result turned heads. A plant alkaloid from goldenseal and Chinese goldthread, matching a first-line pharmaceutical with six decades of clinical validation? The data was real. But the context matters enormously, and most articles about this comparison get the context wrong.

Metformin is FDA-approved, backed by the landmark UKPDS trial of 1,704 overweight patients showing 36% reduced all-cause mortality over 10.7 years of follow-up, and covered by insurance. Berberine is sold as a supplement with no regulatory oversight on potency or purity, limited long-term safety data, and meaningful drug interaction risks. Equivalent blood sugar numbers in one small trial does not mean equivalent clinical standing. Not even close.

But if you're someone exploring metabolic support options without a prescription, or if you want to understand what the science actually shows before your next doctor's appointment, here's what 50+ clinical trials and three meta-analyses tell us.

Two different engines, one overlapping target

Berberine and metformin both activate AMP-activated protein kinase (AMPK). That's the headline everyone repeats, and it's accurate as far as it goes. AMPK is an enzyme that acts as a cellular energy sensor, flip it on, and your cells start pulling in more glucose, burning more fat, and telling the liver to knock it off with the excess glucose production.

But here's the part that gets glossed over in every "nature's metformin" blog post: the molecular paths to AMPK activation are completely different. And that actually matters if you're trying to decide between the two.

Metformin works primarily by inhibiting mitochondrial Complex I in the electron transport chain. Reduced energy production raises the AMP-to-ATP ratio, which triggers AMPK. It also suppresses hepatic gluconeogenesis through mechanisms that may be partly AMPK-independent — the full picture is still being worked out, even after 60 years of research.

Berberine takes a different route. It accumulates in mitochondria and inhibits Complex I as well, but also activates AMPK through upstream kinase LKB1 and modulates the gut microbiome, increasing short-chain fatty acid production and Akkermansia muciniphila abundance. According to a 2025 comprehensive review by Młynarska and colleagues at Medical University of Lodz, berberine's effects extend to epigenetic modifications, GLP-1 secretion, and anti-inflammatory pathways that metformin doesn't directly engage (Młynarska et al., 2025, Pharmaceuticals, PMC).

Berberine and metformin both converge on AMPK, but berberine engages additional gut, hormonal, and epigenetic pathways. Metformin has proven cardiovascular mortality reduction that berberine hasn't demonstrated in large trials.

The practical difference? Berberine pulls double duty on lipids and inflammation markers in ways metformin doesn't. A 2022 meta-analysis of 37 RCTs (3,048 patients) found berberine significantly reduced total cholesterol, LDL cholesterol, and triglycerides alongside glucose, something metformin alone generally doesn't accomplish (Xie et al., 2022, Frontiers in Pharmacology, PMC).

Metformin's edge is cardiovascular protection. The UKPDS showed that metformin reduced all-cause mortality by 36% and any diabetes-related endpoint by 32% in overweight patients over 10.7 years of follow-up. No berberine trial has come close to matching that. When you're choosing between these two, the mechanism overlap is interesting. The outcome gap in long-term mortality data is what actually matters.

The head-to-head trial: what the numbers say

The Yin 2008 study remains the only published randomized trial directly comparing berberine to metformin in the same population at the same dose. It's worth looking at the actual numbers rather than the summary headline.

Marker	Berberine (n=18)	Metformin (n=18)
HbA1c change	9.5% → 7.5% (−2.0%)	Similar magnitude
Fasting glucose	10.6 → 6.9 mmol/L (−35%)	Comparable reduction
Postprandial glucose	19.8 → 11.1 mmol/L (−44%)	Comparable reduction
Triglycerides	1.13 → 0.89 mmol/L (−21%)	No significant change
Dose	500 mg × 3 daily	500 mg × 3 daily
Duration	13 weeks

Source: Yin et al., 2008, Metabolism. Study A: 36 newly diagnosed adults randomized 1:1. All values are from the berberine group; metformin showed "similar" reductions per the study authors. Exact metformin arm figures not reported separately in the abstract. PMID: 18442638.

Thirty-six participants. That's tiny. Any honest reading of this trial has to start there. Eighteen people per arm doesn't give you the statistical power to detect anything except a very large difference — and since no large difference existed, the conclusion is "not detectably different," which is not the same as "proven equivalent." Those are meaningfully different claims, and the supplement industry has been blurring the line between them for fifteen years.

In Study B of the same paper, 48 adults with poorly controlled blood sugar added berberine to their existing medication regimen. HbA1c fell from 8.1% to 7.3% over 3 months. Clinically meaningful, but that was an add-on design without a control arm, making it harder to isolate berberine's contribution.

The meta-analysis picture: 50 trials, 4,150 people

A single 36-person trial wouldn't be enough to build a case on. Fortunately, berberine has been studied extensively in randomized controlled settings, just not as extensively as metformin.

The most recent systematic review, published November 2024 by Wang and colleagues at Shandong University of Traditional Chinese Medicine, pooled 50 RCTs with 4,150 participants. Berberine alone reduced fasting plasma glucose by 0.59 mmol/L, 2-hour postprandial glucose by 1.57 mmol/L, LDL cholesterol by 0.30 mmol/L, and triglycerides by 0.35 mmol/L, all statistically significant. When combined with existing blood sugar medications, the reductions were even larger: fasting glucose dropped 0.99 mmol/L and HbA1c dropped 0.69% (Wang et al., 2024, Frontiers in Pharmacology, PubMed).

For context, metformin typically reduces HbA1c by 1.0–1.5% and fasting glucose by 1.1–1.4 mmol/L in clinical trials. Berberine's solo effect is in the same ballpark but consistently on the lower end. The gap widens further when you compare the evidence depth: metformin has been tested in trials with thousands — sometimes tens of thousands, of participants, over decades of follow-up.

What about weight loss?

Both berberine and metformin can nudge the scale down a little. But let's be clear: neither one is a weight loss drug. I've seen TikTok videos calling berberine "nature's Ozempic" and that's the kind of claim that makes endocrinologists grind their teeth. The pharmacology isn't remotely comparable. Set expectations accordingly.

In the Zhang 2008 placebo-controlled trial at Shanghai's Ruijin Hospital, 116 participants with blood sugar and lipid concerns received either berberine (1.0 g daily) or placebo for 3 months. The berberine group saw fasting glucose fall from 7.0 to 5.6 mmol/L, HbA1c from 7.5% to 6.6%, and triglycerides from 2.51 to 1.61 mmol/L, all significantly better than placebo. According to senior author Guang Ning, MD, PhD, at Ruijin Hospital (Shanghai Jiao Tong University), the metabolic improvements were accompanied by modest body composition changes, though the study's primary endpoints focused on glycemic and lipid markers rather than weight (Zhang et al., 2008, Journal of Clinical Endocrinology & Metabolism, PubMed).

Metformin does roughly the same: a 2–3 kg loss over months, mostly from reduced hepatic glucose output and mild appetite reduction. The Diabetes Prevention Program found metformin produced 2.1 kg average weight loss over 2.8 years compared to placebo.

Neither compound will replace dietary changes and exercise for meaningful weight management. For a broader look at what the evidence supports: berberine for weight loss.

PCOS: where berberine has genuine advantages

Polycystic ovary concerns represent one area where berberine may actually outperform metformin on certain endpoints. Three RCTs have now compared them head-to-head in this population.

The most cited is Wei et al. (2012) at Harbin Medical University, which randomized 89 women and found berberine reduced waist-to-hip ratio from 0.89 to 0.82, a significantly greater improvement than metformin achieved — with comparable effects on insulin sensitivity and fasting insulin (Wei et al., 2012, European Journal of Endocrinology, PubMed). An et al. (2014) studied 150 women undergoing IVF and found berberine lowered total testosterone more effectively than metformin while producing similar reductions in BMI and insulin resistance (An et al., 2014, Clinical Endocrinology, PubMed). A third trial, Mishra et al. (2022), compared berberine, myoinositol, and metformin across three groups, concluding berberine "may have greater potential to reduce cardiovascular risk than metformin in PCOS patients" based on its superior lipid and hormonal improvements (PubMed).

Why might berberine have an edge here? The lipid-lowering and anti-inflammatory effects that go beyond AMPK activation. PCOS involves metabolic, hormonal, and inflammatory dysfunction at once, and berberine's multi-target profile may address more of those nodes than metformin alone.

A major caveat: all three trials were conducted in China, with small sample sizes and short durations. The results are promising enough to warrant a conversation with your gynecologist or endocrinologist, but not strong enough to make blanket recommendations. More detail: berberine for PCOS.

Side effects: the GI divide

Metformin's most notorious side effect is GI distress: diarrhea, nausea, and abdominal cramping. Depending on the study, 20–30% of metformin users experience GI symptoms significant enough to mention. Extended-release formulations (metformin ER) reduce this, but don't eliminate it. A small percentage of users can't tolerate metformin at any dose.

Berberine's GI profile is almost the mirror image. The most common complaint is constipation, not diarrhea, because berberine has antimicrobial activity that can shift gut flora, and in the Wang 2024 meta-analysis, gastrointestinal adverse events were the most frequently reported side effect of berberine, but the total incidence was lower than metformin's in comparative studies.

Other berberine concerns worth knowing: it inhibits CYP3A4, CYP2D6, and P-glycoprotein — liver enzymes and transporters that metabolize a long list of medications. Statins, SSRIs, blood thinners, immunosuppressants, and many others can have their blood levels altered by berberine. This is not a minor footnote. If you take prescription medications, a berberine-drug interaction check with your pharmacist is non-negotiable. Full safety breakdown: is berberine safe long-term?

Metformin carries its own interaction profile (iodinated contrast dye is the big one, and excessive alcohol is another), plus the rare but serious risk of lactic acidosis in people with kidney impairment. Both compounds deserve respect.

For more on berberine-specific concerns: berberine side effects.

Berberine or metformin: which one fits you?

This isn't a one-size answer. It depends on whether you're already on medication, what you're optimizing for, and how much ambiguity you're comfortable with in the evidence. The flowchart below walks you through the decision in about 30 seconds.

Can berberine replace metformin?

No. Not without medical supervision, and not based on current evidence.

This isn't a diplomatic hedge. The data genuinely doesn't support swapping a prescribed medication for an unregulated supplement. Here's why:

Start with regulatory oversight. Every batch of metformin meets pharmaceutical-grade purity and potency standards. Berberine supplements vary wildly, a 2019 ConsumerLab analysis found that some products contained 20–30% less active ingredient than their labels claimed. You can't dose something precisely if the product itself isn't precise.

Then there's the long-term outcome data. The UKPDS follow-up showed sustained mortality benefits extending 10+ years after the trial ended. No berberine trial has lasted longer than 16 weeks or tracked cardiovascular events as a primary endpoint.

And pharmacokinetics. We know exactly how metformin is absorbed, distributed, and eliminated. Berberine's oral bioavailability is notoriously poor, roughly 5% absorption — which is why the effective dose is 1,500 mg/day split across meals. Newer formulations like berberine phytosome claim improved absorption, but the clinical data behind those claims is still thin.

What berberine can do: serve as a reasonable option for people who aren't on prescription medication but want evidence-based metabolic support. If your fasting glucose runs slightly elevated and your doctor says "let's watch it," berberine plus lifestyle changes is a legitimate strategy to bring to that conversation.

Why doctors still choose metformin first

I know this section won't be popular with the supplement crowd. But if you're reading a comparison article and it doesn't tell you why metformin wins on certain fronts, it's selling you something instead of informing you.

Cost, for starters. A month of metformin runs about $4 at most pharmacies with a GoodRx coupon. Berberine typically costs $20–35 per month for a quality product.

Standardization is another. Every 500 mg tablet contains exactly 500 mg of metformin hydrochloride, verified by the FDA. Berberine supplement potency depends on the brand's manufacturing practices and third-party testing rigor, which ranges from excellent to nonexistent.

There's also the anti-aging angle. The TAME (Targeting Aging with Metformin) trial is currently enrolling thousands of participants to test whether metformin extends healthspan. Berberine has theoretical longevity mechanisms through AMPK and sirtuin pathways, but no equivalent trial is underway.

Dr. Layth Tumah, a functional medicine specialist at Cleveland Clinic, put it bluntly: metformin has a "long-term history of studies that back [its] use, with established treatment dose, mechanism of action, safety and side effect profile", advantages that berberine can't yet match yet (Cleveland Clinic, 2025). Coming from a practicing physician at one of the world's top medical centers weighing in, not a supplement influencer.

The NCCIH (National Center for Complementary and Integrative Health) echoes the same caution: "berberine might help lower blood sugar, but the research isn't strong enough to determine how well it works." That's an institutional assessment from NIH, and it accurately reflects the state of the evidence.

None of this means berberine is worthless. It means the two compounds aren't interchangeable, and framing berberine as "nature's metformin" overpromises and underdelivers.

Is berberine FDA approved?

No. Berberine is classified as a dietary supplement in the United States, which means it's regulated under DSHEA (the Dietary Supplement Health and Education Act of 1994) — not under the same framework as pharmaceutical drugs. In practical terms, this means:

No pre-market approval is required. A company can start selling berberine tomorrow without demonstrating efficacy to anyone. Metformin went through Phase I, II, and III clinical trials before the FDA approved it in 1994.

No mandatory potency verification. The FDA can pull a supplement off shelves after problems are reported, but doesn't proactively test products for accuracy. That ConsumerLab finding about 20–30% potency variance? It's legal. Disappointing, but legal.

No standardized dosing guidelines. Your doctor can look up metformin in any prescribing reference and find exact dosing protocols by indication, body weight, and renal function. For berberine, the "recommended dose" comes from clinical trial protocols and supplement brand labels, which don't always agree with each other.

This doesn't make berberine dangerous. Plenty of well-studied, beneficial compounds aren't FDA-approved drugs. But it does mean the burden of quality control shifts from the government to the manufacturer, and in the end to you, the buyer. Choosing a brand that publishes third-party COAs isn't optional; it's the only way to know what's actually in the bottle.

Can you take berberine and metformin together?

Some people do, under medical supervision. The pharmacological rationale is real — berberine's gut microbiome and GLP-1 effects don't fully overlap with metformin's primary mechanism, so there's theoretical room for additive benefit.

Study B in the Yin 2008 trial added berberine to existing oral glucose medications (including metformin) and saw HbA1c drop from 8.1% to 7.3%. But the risk is also real: stacking two glucose-lowering compounds increases the chance of blood sugar dropping too low, especially if diet or exercise patterns change simultaneously.

If you're considering this combination, your doctor needs to know. Blood sugar monitoring becomes more important, not less. We have a full breakdown here: can you take berberine and metformin together?

Research that's still underway

One of the biggest frustrations with the berberine evidence base is that the landmark head-to-head trial is from 2008, and nobody has repeated it at adequate scale. That may finally be changing.

NCT03029390 is a randomized, double-blind trial at a Mexican university hospital comparing berberine 500 mg three times daily against metformin 850 mg twice daily in adults with prediabetes, specifically impaired fasting glucose and impaired glucose tolerance. The primary endpoints are glycemic control, insulin sensitivity (via hyperinsulinemic-euglycemic clamp, the gold standard), and insulin secretion. If completed and published, this would be the first double-blind, active-comparator trial between berberine and metformin. Every previous study was either open-label or single-blind.

Beyond this, a 2023 preclinical study from Jian-Dong Jiang's group at the Chinese Academy of Medical Sciences directly compared berberine and metformin in high-fat-diet hamsters and ApoE-knockout mice. The finding: berberine was "a potential alternative for metformin with good regulatory effect on lipids", but they were careful to note that berberine's advantage was specific to lipid regulation, not glucose control as a whole (Li et al., 2023, Phytotherapy Research, PubMed). That's an animal model, not a human trial, but it reinforces the pattern: berberine's edge is multi-target metabolic modulation, not raw glucose-lowering power.

We'll update this section as new data publishes. The field is moving — just not as fast as the marketing departments.

How to choose a berberine supplement

Most berberine on the market is berberine hydrochloride (HCl), which is the form used in nearly all clinical trials. If a product doesn't specify the salt form, assume it's HCl, but check anyway.

What to look for:

Third-party testing. A Certificate of Analysis from an independent, ISO 17025-accredited lab. Not "tested in-house." Not "GMP certified" (that's a manufacturing standard, not a potency verification). Actual third-party COAs with batch numbers.

Dose transparency. The clinically studied dose is 500 mg taken 2–3 times daily with meals, totaling 1,000–1,500 mg per day. Any product asking you to take a single 500 mg capsule once daily is underdosing you relative to the research. Details: berberine dosage guide.

Realistic claims. If the label or website says "better than metformin" or "cures blood sugar problems," move on. That's a compliance violation and a signal that the company prioritizes marketing over accuracy.

Among nationally distributed brands, here's how the most common options stack up. I looked at what's actually on the label, what independent testing confirms, and what you're paying per milligram of berberine.

Brand	Dose/Serving	Form	3rd-Party Tested	~Price/Month	Public COA
Thorne Berberine-500	500 mg × 2	HCl	Yes (NSF)	$34	No
NOW Foods Berberine Glucose Support	400 mg × 3	HCl	Yes (UL)	$22	No
Life Extension Optimized Berberine	400 mg × 2	Dihydroberberine	Yes	$28	No
Nutricost Berberine HCl	500 mg × 3	HCl	Yes (ISO)	$15	No
YourHealthier Berberine	800 mg × 2	HCl (dual-extract)	Yes (ISO 17025)	$33	Yes

Prices approximate as of May 2026 based on retail pricing at standard serving frequency. All brands listed use berberine HCl except Life Extension (dihydroberberine). "3rd-party tested" means the brand states independent lab verification on their website or label; "Public COA" means batch-specific Certificates of Analysis are accessible without emailing customer service.

Thorne is the premium pick. NSF-certified, pharmaceutical-grade sourcing, consistently clean independent testing results. You pay for it. NOW Foods is the budget workhorse: solid quality, lower cost, but you need three capsules a day to hit clinical doses. Life Extension uses dihydroberberine, which they claim absorbs 5× better than standard HCl. The mechanism is plausible — dihydroberberine is the active metabolite, but peer-reviewed head-to-head pharmacokinetic studies in humans comparing blood levels are limited to one small, manufacturer-funded trial. Not enough to justify the upcharge for most people.

Nutricost wins on price-per-milligram by a wide margin. The trade-off: their brand doesn't publish COAs publicly, and their formulations are bare-bones (no added bioavailability enhancers). If cost is your primary constraint and you trust their ISO-accredited testing claim, it's a legitimate option.

Why we chose this formulation

Our berberine provides 800 mg of berberine hydrochloride per serving, a dose that aligns with the mid-range of the 1,000–1,500 mg daily protocols from published trials when taken twice daily. We chose HCl because it's the form with the most clinical data behind it, not because it's the cheapest or easiest to source.

Every batch undergoes third-party testing for potency (berberine content ≥95%), heavy metals (arsenic, lead, mercury, cadmium), and microbial contamination. Our most recent batch (Lot #2026-04) tested at 97.3% berberine HCl purity with all four heavy metals below detectable limits — results you can verify on our Lab Results page. We post the actual numbers. If they looked bad, we wouldn't hide them behind a customer service email, we'd reformulate.

What we don't claim: that our berberine is a substitute for medical treatment, that it will produce the same results as metformin for everyone, or that taking it means you can ignore your doctor's advice. The data supports berberine as a useful metabolic tool. The data does not support it as a pharmaceutical replacement.

Who should be cautious

Anyone on prescription blood sugar medication. Adding berberine to metformin, sulfonylureas, or insulin without medical guidance risks pushing glucose too low. Hypoglycemia is not a minor inconvenience, it can be dangerous.

Anyone taking CYP3A4-metabolized drugs. This includes many statins (atorvastatin, simvastatin), certain antidepressants, immunosuppressants like cyclosporine, and blood thinners like warfarin. Berberine can raise blood levels of these medications unpredictably. Check with your pharmacist.

Pregnant or breastfeeding women. Berberine crosses the placenta and has shown embryotoxicity in animal models. This is a hard no during pregnancy, not a "probably fine" situation.

People with low blood pressure. Berberine has mild hypotensive effects. If you already run low, this could push you into symptomatic territory — lightheadedness, fatigue, fainting.

Kidney or liver impairment. Berberine is metabolized hepatically and cleared renally. Impaired function in either organ alters blood levels in ways that haven't been studied adequately. Same caution applies to metformin for kidney function, by the way.

Berberine vs metformin: the full comparison

	Berberine	Metformin
Type	Dietary supplement (plant alkaloid)	Prescription drug (biguanide)
FDA approved	No	Yes (since 1994 in US)
HbA1c reduction	−0.69% to −2.0% (varies by trial)	−1.0% to −1.5% (typical)
Lipid effects	↓ LDL, ↓ TG, ↓ TC (significant)	Minimal lipid effect
CV outcome data	None	UKPDS: −36% all-cause mortality
Main GI side effect	Constipation	Diarrhea, nausea
Drug interactions	CYP3A4, CYP2D6, P-gp inhibitor	Iodinated contrast, alcohol
Clinical evidence	50 RCTs, 4,150 participants	Hundreds of trials, tens of thousands
Cost (US)	$20–35/month (supplement)	$4–10/month (generic Rx)
Typical dose	500 mg × 2–3 daily with meals	500–1000 mg × 2 daily with meals
Best for	People not on Rx seeking metabolic support; lipid + glucose combo	First-line Rx for blood sugar management with proven CV protection

Related supplements worth knowing about

Berberine works through AMPK. If you're building a broader metabolic support protocol, other pathways are worth covering too:

• Magnesium Glycinate, supports insulin sensitivity through a completely separate mechanism (Mg²⁺ is a cofactor for >300 enzymes including several in glucose metabolism). About half of Americans fall short on magnesium. See: magnesium glycinate benefits
• Ashwagandha KSM-66, cortisol management. Chronically elevated cortisol raises blood sugar through gluconeogenesis. An RCT showed 27.9% cortisol reduction over 60 days. See: ashwagandha and cortisol
• NMN — supports NAD+ levels, which decline with age and are involved in cellular energy regulation. A different axis entirely from AMPK. See: NMN benefits

For stacking berberine with other supplements: berberine and ashwagandha together · berberine and magnesium together · berberine and inositol.

Related reading

• Berberine Benefits: What It Does for Blood Sugar, Metabolism, and More
• Berberine Dosage: How Much Per Day? 500mg vs 1500mg Explained
• Best Time to Take Berberine: Morning or Night?
• Berberine for Cholesterol: What 41 Clinical Trials Show
• Berberine and Gut Health
• How Long Does Berberine Take to Work?
• Is Berberine Bad for Kidneys?
• Can You Take Berberine and Ashwagandha Together?

What is berberine?

Berberine is a bioactive compound found in plants like goldenseal and barberry. It activates AMPK, an enzyme involved in cellular energy metabolism. Research includes 50+ RCTs on metabolic markers. See our berberine benefits overview.

What does berberine do?

Berberine activates AMPK (your cells’ metabolic master switch) to support blood sugar regulation, LDL cholesterol reduction via the PCSK9/LDLR pathway, and triglyceride lowering. Clinical evidence is strongest for people with pre-existing metabolic dysfunction. See our full breakdown of berberine benefits.

What is berberine used for?

The strongest clinical evidence for berberine is in blood sugar regulation (HbA1c and fasting glucose reduction comparable to metformin in some trials), LDL cholesterol reduction (up to 25% via the PCSK9 pathway), triglyceride lowering, and modest weight management support in metabolically impaired individuals. Emerging data also supports gut microbiome modulation and PCOS-related hormonal balance. See our full breakdown in the berberine benefits guide.

References

1. Yin J, Xing H, Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism. 2008;57(5):712-717. PubMed
2. Zhang Y, Li X, Zou D, et al. Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine. Journal of Clinical Endocrinology & Metabolism. 2008;93(7):2559-2565. PubMed
3. Wang J, Bi C, Xi H, Wei F. Effects of administering berberine alone or in combination on type 2 diabetes mellitus: a systematic review and meta-analysis. Frontiers in Pharmacology. 2024;15:1455534. PubMed
4. Xie W, Su F, Wang G, et al. Glucose-lowering effect of berberine on type 2 diabetes: a systematic review and meta-analysis. Frontiers in Pharmacology. 2022;13:1015045. PMC
5. Guo J, Chen H, Zhang X, et al. The effect of berberine on metabolic profiles in type 2 diabetic patients: a systematic review and meta-analysis of randomized controlled trials. Oxidative Medicine and Cellular Longevity. 2021;2021:2074610. PubMed
6. Młynarska E, Czarnik W, Dzieża N, et al. Berberine: a rising star in the management of type 2 diabetes, novel insights into its anti-inflammatory, metabolic, and epigenetic mechanisms. Pharmaceuticals. 2025;18(12):1890. PMC
7. Wei W, Zhao H, Wang A, et al. A clinical study on the short-term effect of berberine in comparison to metformin on the metabolic characteristics of women with polycystic ovary syndrome. European Journal of Endocrinology. 2012;166(1):99-105. PubMed
8. An Y, Sun Z, Zhang Y, et al. The use of berberine for women with polycystic ovary syndrome undergoing IVF treatment. Clinical Endocrinology. 2014;80(3):425-431. PubMed
9. Mishra N, Verma R, Jadaun P. Study on the effect of berberine, myoinositol, and metformin in women with polycystic ovary syndrome: a prospective randomized study. Cureus. 2022;14(1):e21781. PubMed
10. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). The Lancet. 1998;352(9131):854-865. PubMed
11. National Center for Complementary and Integrative Health (NCCIH). "Diabetes and Dietary Supplements: What You Need To Know." nccih.nih.gov
12. Guo HH, Shen HR, Wang LL, et al. Berberine is a potential alternative for metformin with good regulatory effect on lipids in treating metabolic diseases. Phytotherapy Research. 2023;163:114754. PubMed
13. ClinicalTrials.gov. "Effect of Berberine Versus Metformin on Glycemic Control, Insulin Sensitivity and Insulin Secretion in Prediabetes." Identifier: NCT03029390. clinicaltrials.gov

---

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Always consult your healthcare provider before starting any new supplement, especially if you take prescription medications.

Disclosure: YourHealthier manufactures and sells the berberine supplement discussed in this article. We do not sell metformin. All health claims are based on published peer-reviewed research cited above. We earn revenue from product sales linked in this article.

Lab Results · Our Science · Editorial Policy

Sources verified: All PubMed citations and external references in this article were last verified on May 25, 2026.